Study on Iron Integration in Anaemias and New Pharmaceutical Technologies Correlation between Pharmaceutical Iron Technology and the Effectiveness of Supplements

Abstract

Iron is one of the most important elements for human, because it plays an essential role in many metabolic processes. However, it is also recognized to be dangerous for its detrimental effect inside human cells, where, in the absence of homeostatic balance, it can induce free radicals formation. Although iron is one of the essential trace elements for living organisms, including man, since it performs multiple metabolic and biological synthesis functions, on the other hand, it presents a reduced tolerance for the important risks associated with its intake.

Moreover, an excessive accumulation of iron in tissues can produce iron overloading, a condition incompatible with life. The use of liposomes as carriers can represent an interesting iron therapy to improve iron bioavailability and reduce its negative effects, in particular during pregnancy.

In this study we present the results of Post Marketing Surveillance on an Ferrous-sulphate in liposomes based product plus B-complex vitamins (Iron-folic) in the years 2017-2018, and Technological Up-grading.